Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
952.74
-1.43 (-0.15%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eli Lilly
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Prediction: These Will Be the Best-Performing S&P 500 Stocks of 2024
Today 5:50 EDT
The S&P 500's top three at year-end could look a little different than they do now.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
AskSlim Market Week - Friday, Aug. 23
August 23, 2024
An analysis and commentary on the financial markets.
Via
Talk Markets
Why Apple Stock And This 'Recession-Proof' Leader Strengthen Market's Bull Case
August 23, 2024
What happens when you get rate cuts as a tech revolution is starting? An environment that's set to supercharge the stock market, says this expert.
Via
Investor's Business Daily
Stock Market Rallies As Powell Confirms Rate Cuts; Palo Alto, Cava, Target Jump: Weekly Review
August 23, 2024
Palo Alto and Cava were among the earnings winners.
Via
Investor's Business Daily
Exploring The Competitive Space: Eli Lilly Versus Industry Peers In Pharmaceuticals
August 23, 2024
Via
Benzinga
Check Out What Whales Are Doing With LLY
August 22, 2024
Via
Benzinga
The Stock Market Isn't Rocking This Month But The S&P 500 Is Headed For Its Best August In 3 Years
August 23, 2024
Kellanova and Fortinet are leading the S&P 500's August performance.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Visualizing The World’s Top 25 Companies By Market Cap
August 23, 2024
The world’s top 25 companies by market capitalization.
Via
Talk Markets
RedHill's Opaganib Shows Diabetes And Obesity Potential With Positive In Vivo Results
August 23, 2024
RedHill's Opaganib Shows Diabetes And Obesity Potential With Positive In Vivo Results
Via
News Direct
These Were the Top-Selling GLP-1 Drugs Last Quarter From Eli Lilly and Novo Nordisk
August 23, 2024
Ozempic remains on top in the GLP-1 drug market -- but for how long?
Via
The Motley Fool
Eli Lilly Hits All-Time High, Gets Watchlist Trifecta: These Names Just Added To IBD 50, Other Top Stock Screens
August 22, 2024
Eli Lilly deserved landing on three top stock lists. The drug giant hit an all-time high Thursday and has surging earnings and revenue.
Via
Investor's Business Daily
Eli Lilly's Growth Rate Is Fantastic, but This Number Is Even Better
August 22, 2024
Eli Lilly's valuation may seem high right now, but with fast earnings growth, today's price could look like a deal in a few years.
Via
The Motley Fool
This Undervalued Stock Could Join the Race With Eli Lilly to the $1 Trillion Club
August 22, 2024
This leading pharmaceutical stock is flying under the radar right now.
Via
The Motley Fool
Wegovy Now Available Through Sesame's $249 Monthly Compounded Program Despite Supply Shortages
August 21, 2024
Sesame introduces an affordable weight loss program with compounded versions of Wegovy amid supply shortages. The program provides a $249 monthly alternative to expensive obesity treatments.
Via
Benzinga
Novo Nordisk Vs. Eli Lilly: Beyond The Weight-Loss Drug Battle
August 21, 2024
Novo Nordisk and Eli Lilly are competing for the obesity-drug market, but their growth plans extend beyond weight-loss treatments. They face supply chain challenges, but both stocks show strong bullish...
Via
Benzinga
Topics
Economy
Exposures
Supply Chain
Asia Mixed, European Markets Advance; Gold Stays Near All Time High While Dollar Gains - Global Markets Today While US Slept
August 21, 2024
US stock markets close lower, breaking 8-day winning streak as investors pause before economic symposium. Energy stocks decline, consumer staples gain.
Via
Benzinga
Eli Lilly Stock Could Soar to $1,150, According to a Wall Street Analyst. Is It a Buy at Around $945?
August 21, 2024
The Big Pharma stock is up by more than 50% in 2024, but investment-bank analysts think it has more room to run.
Via
The Motley Fool
Why Eli Lilly Topped the Market on Tuesday
August 20, 2024
The company had very encouraging news to report about its hottest product.
Via
The Motley Fool
Biotech Bull Market: 3 Ways To Play It
August 20, 2024
Although we are in the later stages of this bull market a cut in interest rates by the Fed should help biotech as you have seen from the recent rally.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
Wall Street Eases, Bonds Rises, US Dollar Falls To 8-Month Low: What's Driving Markets Tuesday?
August 20, 2024
It’s a relatively uneventful session on Wall Street, but with a slightly worsening risk sentiment as all U.S. equity indices traded in the red at around midday trading in New York.
Via
Benzinga
Fabrinet Posts Strong Earnings, Joins Amer Sports, Hawaiian Holdings And Other Big Stocks Moving Higher On Tuesday
August 20, 2024
Via
Benzinga
Eli Lilly, An IBD 50 Stock, Nears Record High On Another Weight-Loss Win
August 20, 2024
The company tested tirzepatide in patients with prediabetes and obesity over three years.
Via
Investor's Business Daily
Merck's Stock Dip Offers a Buying Opportunity: Here’s Why
August 20, 2024
Global big pharmaceutical company Merck & Co. Inc. (NYSE: MRK) shares sank 9% following its Q2 2024 earnings release. Merck beat top and bottom line estimates,
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
Eli Lilly's Famed Obesity/Diabetes Treatment Tirzepatide Shows Potential To Cut Risk Of Developing Diabetes, Sustained Weight Loss Over 3 Years
August 20, 2024
Eli Lilly's SURMOUNT-1 three-year study reveals tirzepatide's effectiveness in reducing type 2 diabetes risk and achieving significant long-term weight loss in adults with pre-diabetes and obesity.
Via
Benzinga
1 Surefire Warren Buffett Index Fund Could Turn $400 Per Month Into $902,000
August 20, 2024
This reliable investment strategy has never failed to make money over 20-year holding periods.
Via
The Motley Fool
Three Biotech Stocks to Buy for the "Golden Age of Medicine"
August 19, 2024
Experts declare 'Golden Age of Medicine' with surge of new drug and medical discoveries. Biotech stocks like Eli Lilly and Sanofi are thriving.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
August 19, 2024
Via
Benzinga
Walmart Wins Bargain Games
August 19, 2024
The world's largest retailer is crushing the market.
Via
The Motley Fool
Telehealth Firm Hims & Hers Health Rides High On Demand for Copycat Weight Loss Drugs Amid Supply Shortages
August 19, 2024
Hims & Hers Health has seen its stock rise over 120% due to soaring demand for its affordable compounded GLP-1 weight-loss drugs, despite legal battles and safety concerns surrounding its...
Via
Benzinga
Prediction: These 2 Unstoppable Pharma Stocks Will Continue to Soar Through 2025 and Beyond
August 19, 2024
Impediments to growth are melting away while new opportunities begin to rise.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.